首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   347篇
  免费   37篇
  国内免费   8篇
化学   389篇
物理学   3篇
  2023年   6篇
  2022年   8篇
  2021年   6篇
  2020年   12篇
  2019年   13篇
  2018年   6篇
  2017年   7篇
  2016年   6篇
  2015年   18篇
  2014年   28篇
  2013年   35篇
  2012年   26篇
  2011年   26篇
  2010年   18篇
  2009年   14篇
  2008年   23篇
  2007年   21篇
  2006年   20篇
  2005年   22篇
  2004年   23篇
  2003年   17篇
  2002年   11篇
  2001年   2篇
  2000年   4篇
  1999年   1篇
  1998年   2篇
  1997年   2篇
  1996年   2篇
  1995年   6篇
  1994年   1篇
  1992年   2篇
  1991年   1篇
  1990年   2篇
  1986年   1篇
排序方式: 共有392条查询结果,搜索用时 31 毫秒
101.
Starting from a readily available enantiopure building block, a straightforward enantioselective approach to 3′-methyl-2′,3′-β-oxirane-fused carbanucleosides bearing adenosine analogues is detailed. The key steps in the syntheses involved a lipase-catalyzed regioselective monoacylation of a diol to obtain the key intermediate and direct coupling of this key intermediate with diversely substituted purine nucleobases under Mitsunobu reaction conditions providing only the N9 target molecules.  相似文献   
102.
Summary Modified nucleosides excreted in urine have been studied as potential diagnostic markers for cancer and AIDS, and as indicators for the whole-body turnover of RNA. Until now, reversed-phase (RP) HPLC and, to some extent, immunoassays are the preferred analytical methods for urinary nucleosides. A new capillary electrophoretic method for the analysis of normal and modified nucleosides in urine has been developed and optimized in our laboratory. The separation of nucleosides extracted from normal human urine on phenyl boronic acid affinity chromatography columns was performed in uncoated 565 mm (500 mm to detection window) × 50 μm i.d. capillary tubing using a 300 mM SDS—25 mM borate—50 mM phosphate buffer (pH 6.7), a 45-s load, a voltage of 7.5 kV (41 μA) and UV detection at 260 and 210 nm. The average recovery of the nucleosides was 91 %. The calibration curves were linear over all physiological and pathophysiological concentration ranges and the limits of detection were at micromolar levels. Reproducibility of migration times were better than 1 % (coefficient of variation,CV), and the reproducibilities of the determined concentrations were better than 5 % for standards and 6–15 % for extracted urine. The developed method was used to quantify 15 normal and modified nucleosides in 25 normal urines to establish reference ranges. The analysis time was less than 45 min. Dedicated to Professor E. Bayer on the occasion of his 70th birthday. Presented at the 21st ISC held in Stuttgart, Germany, 15th–20th September, 1996.  相似文献   
103.
This is the third and the last part of three closely interrelated reviews dealing with computation of 1H nuclear magnetic resonance chemical shifts and 1H–1H spin–spin coupling constants. Present review deals with the computation of these parameters in biologically active natural products, carbohydrates, and other molecules of biological origin focusing on stereochemical applications of computational 1H nuclear magnetic resonance to these objects.  相似文献   
104.
105.
106.
Although numerous reports on the synthesis of atom‐specific 15N‐labeled nucleosides exist, fast and facile access to the corresponding phosphoramidites for RNA solid‐phase synthesis is still lacking. This situation represents a severe bottleneck for NMR spectroscopic investigations on functional RNAs. Here, we present optimized procedures to speed up the synthesis of 15N(1) adenosine and 15N(1) guanosine amidites, which are the much needed counterparts of the more straightforward‐to‐achieve 15N(3) uridine and 15N(3) cytidine amidites in order to tap full potential of 1H/15N/15N‐COSY experiments for directly monitoring individual Watson–Crick base pairs in RNA. Demonstrated for two preQ1 riboswitch systems, we exemplify a versatile concept for individual base‐pair labeling in the analysis of conformationally flexible RNAs when competing structures and conformational dynamics are encountered.  相似文献   
107.
Acylated nucleoside analogues play an important role in medicinal chemistry and are extremely useful precursors to various other nucleoside analogues. However, chemoselective acylation of nucleosides usually requires several protection and deprotection steps due to the competing nucleophilicity of hydroxy and amino groups. In contrast, direct protecting-group-free chemoselective acylation of nucleosides is a preferred strategy due to lower cost and fewer overall synthetic steps. Herein, a simple and efficient chemoselective acylation of nucleosides and nucleotides under mild reaction conditions, giving either O- or N-acylated products respectively with excellent chemoselectivity is reported.  相似文献   
108.
S?awomir Boncel 《Tetrahedron》2010,66(43):8450-8457
By controlling the temperature or reaction time in the base-catalysed Michael-type addition of 5-substituted uracil derivatives we were able to synthesise N-1 or N-3 uracil adducts using methyl acrylate and acrylonitrile as acceptors. The mechanism of this chemical inequivalence was established using 1H NMR spectroscopic studies. The investigations revealed that formation of the N-1 adduct was achievable under kinetically controlled conditions irrespective to the type of the base used (TEA, DBU). In turn, synthesis of the N-3 adducts proceeded from the initially formed N-1,N-3 diadduct via a retro-Michael reaction which dominates at elevated temperature or prolonged reaction time.  相似文献   
109.
A straightforward procedure for the preparation of nucleoside analogue 1 and its regioisomer 2 containing a dihydro-1,4-dithiin as sugar moiety has been accomplished in four steps by our readily available heterocyclic system 5. Nucleobase insertion was carried out by direct addition of N4-acetylcytosine to sulfoxide derivatives via Pummerer-type glycosidation reaction.  相似文献   
110.
以2,6-二氯嘌呤核苷和亚磷酸酯为原料,通过微波促进的Arbuzov反应,一步合成6位磷酸酯取代的嘌呤核苷类化合物,然后再进一步衍生,得到6-位磷酸单酯和6-位磷酸取代的嘌呤核苷类新化合物.得到的非环嘌呤核苷类化合物通过核磁共振图谱、高分辨质谱和红外光谱进行了结构确认.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号